Charles River Laboratories International Inc.
CRL | NYSE
$279.01
+$0.95 (+0.34%)
At close: Sep 21, 2026, 4:00 PM ET
$279.01
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:55 PM ET
Fiscal Year Period Ending | FY 2025 Dec 26, 2025 | FY 2024 Dec 27, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 213.77M | 194.61M | 276.77M | 233.91M | 245.24M | 228.42M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | 1.02M |
Long-Term Investments | 206.97M | 218.35M | 243.81M | 311.6M | 201.35M | 221.8M |
Other Long-Term Assets | 293.19M | 278.23M | 309.38M | 148.28M | 151.54M | 130.82M |
Receivables | 708.86M | 720.92M | 780.38M | 752.39M | 650.38M | 617.74M |
Inventory | 299.1M | 278.54M | 380.26M | 255.81M | 199.15M | 185.7M |
Other Current Assets | 8.65M | 105.8M | 83.38M | 107.58M | n/a | 3.07M |
Total Current Assets | 1.45B | 1.4B | 1.61B | 1.44B | 1.27B | 1.2B |
Property-Plant & Equipment | 2.02B | 2.02B | 2.03B | 1.86B | 1.58B | 1.3B |
Goodwill & Intangibles | 3.1B | 3.57B | 3.96B | 3.81B | 3.77B | 2.6B |
Total Long-Term Assets | 5.69B | 6.13B | 6.59B | 6.16B | 5.75B | 4.29B |
Total Assets | 7.14B | 7.53B | 8.2B | 7.6B | 7.02B | 5.49B |
Account Payables | 148.8M | 140.34M | 168.94M | 205.92M | 198.13M | 122.48M |
Deferred Revenue | 210.42M | 248.32M | 241.82M | 264.26M | 219.7M | 250.19M |
Short-Term Debt | 61.06M | n/a | n/a | n/a | 101K | 47.2M |
Other Current Liabilities | 392.19M | 373.43M | 431.04M | 401.65M | 307.01M | 217.5M |
Total Current Liabilities | 1.12B | 994.1M | 1.06B | 1.09B | 1.03B | 839.75M |
Long-Term Debt | 2.55B | 2.24B | 2.65B | 2.71B | 2.92B | 1.9B |
Other Long-Term Liabilities | -341.38M | 195.21M | 223.19M | 174.82M | -30.69M | 185.74M |
Total Long-Term Liabilities | 2.8B | 3.03B | 3.48B | 3.49B | 3.4B | 2.51B |
Total Liabilities | 3.92B | 4.02B | 4.54B | 4.58B | 4.43B | 3.35B |
Total Debt | 3.07B | 2.72B | 3.07B | 3.1B | 3.21B | 2.16B |
Book Value | 3.21B | 3.51B | 3.66B | 3.02B | 2.59B | 2.14B |
Book Value Per Share | 64.79 | 67.95 | 71.12 | 58.94 | 50.40 | 42.36 |
Common Stock | 492K | 511K | 513K | 509K | 505K | 498K |
Retained Earnings | 1.39B | 1.81B | 1.89B | 1.43B | 980.75M | 625.41M |
Comprehensive Income | -171.78M | -317.35M | -196.43M | -262.06M | -164.74M | -138.87M |
Shareholders Equity | 3.16B | 3.46B | 3.6B | 2.98B | 2.53B | 2.11B |
Total Investments | 206.97M | 218.35M | 243.81M | 311.6M | 201.35M | 222.83M |
Add to Watchlist
Select watchlists to add or remove CRL